Skip to main content
Log in

HPV vax looks attractive in developing countries

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim S-Y.Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 26: 4080-4093, No. 32, 29 Jul 2008

  2. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ.Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine 26: 4015-4024, No. 32, 29 Jul 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HPV vax looks attractive in developing countries. Pharmacoecon. Outcomes News 563, 7 (2008). https://doi.org/10.2165/00151234-200805630-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805630-00014

Keywords

Navigation